FDA Extends Comment Period for Report on Non-Standardized Allergenic Extracts

Summary

The Food and Drug Administration (FDA) is extending the comment period for its report on the use of non-standardized allergenic extracts in the diagnosis and treatment of allergic disease until April 25, 2012, in response to input from the Allergenic Products Advisory Committee (APAC).